Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH

PHASE3CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

June 23, 2014

Primary Completion Date

September 19, 2018

Study Completion Date

September 19, 2018

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Macitentan

10 mg once daily

Trial Locations (32)

7010

Hospital Son Espases, Palma de Mallorca

14004

Hospital Reina Sofia, Córdoba

14033

Hôpital Côte de Nacre, Caen

28041

Hospital 12 Octubre, Madrid

28046

Hospital La Paz, Madrid

29010

Hospital Carlos Haya, Málaga

31059

Hôpital Larrey, Toulouse

33604

Hôpital de Haut Levêque, Pessac

34295

Hôpital Arnaud de Villeneuve, Montpellier

35010

Hospital Dr Negrin, Las Palmas de Gran Canaria

35016

Hospital Universitario Insular Gran Canarias, Las Palmas de Gran Canaria

35033

Hôpital Pontchaillou, Rennes

37134

Policlinico G.B. Rossi, Verona

38700

Hôpital Albert Michallon, Grenoble

39008

Hospital de Valdecilla, Santander

40138

Ospedale Sant'Orsola, Bologna

41013

Hospital Virgen del Rocio, Seville

42227

Hôpital Nord, Saint-Etienne

46014

Hospita General U. Valencia, Valencia

48903

Hospital de Cruces, Bilbao

50124

A.O.U.C. Careggi, Florence

54511

Hôpitaux de Brabois, Nancy

59037

CHRU Lille - Hôpital Cardiologique, Lille

67091

Hôpital Civil, Strasbourg

69677

Hôpital Louis Pradel, Bron

76031

Hôpital Charles Nicolle, Rouen

94270

CHU de Bicêtre, Le Kremlin-Bicêtre

00161

UOC Immunologia Clinica B-PGRM Centro di Riferimento per la Sclerosi Sistemica, Rome

00186

Centro Per La Diagnosi E La Cura Dell'Ipertensione Polmonare, Rome

03010

Hospital General de Alicante, Alicante

08035

Hospital Val Hebron, Barcelona

08036

Hospital Clinic, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Actelion

INDUSTRY

NCT02112487 - Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH | Biotech Hunter | Biotech Hunter